dr. simeone on benefit of neoadjuvant gemcitabine in pancreatic cancer
Published 4 years ago • 242 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
1:39
dr. simeone on selecting patients with pancreatic cancer for neoadjuvant therapy
-
1:57
dr. simeone on the importance of germline testing in pancreatic cancer
-
1:17
dr. choti on the benefits of neoadjuvant chemotherapy in pancreatic cancer
-
0:59
dr. simeone on impact of parp inhibitors on pancreatic cancer
-
1:27
dr. simeone on emerging subtypes of pancreatic cancer
-
1:07
dr. katz on neoadjuvant chemotherapy in pancreatic cancer
-
1:16
dr. simeone discusses unmet needs in pancreatic cancer
-
1:38
nepafox: adjuvant gemcitabine vs. folfirinox in resectable pancreatic cancer
-
8:22
pancreatic cancer properties describe gemcitabine response
-
6:44
ongoing neoadjuvant clinical trials in pancreatic cancer
-
7:19
neoadjuvant therapy in resectable pancreatic cancer
-
2:17
dr. barzi on available and emerging neoadjuvant approaches in pancreatic cancer
-
2:13
dr. fine on gtx in inoperable pancreatic cancer
-
6:06
practical considerations in chemotherapy regimens for pancreatic cancer
-
1:26
dr. simone discusses the precision promise trial in pancreatic cancer
-
10:22
resectable pancreatic cancer debate: total neoadjuvant vs adjuvant therapy - total neoadjuvant
-
1:04
does neoadjuvant chemotherapy have a role in resectable pancreatic cancer?
-
3:59
adjuvant mfolfirinox shows benefits over gemcitabine in pancreatic cancer | thierry conroy
-
9:47
role of chemoradiation in resectable pancreatic cancer